Virtual Medicinal Product (VMP) - Neostigmine 30mg/5ml oral solution
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Neostigmine 30mg/5ml oral solution | Start Date 14-10-2009 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral solution
- Ontology Form/Route
- solution.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- N07AA01
- BNF Codes
-
- BNF code 10020100
| Code | Start Date | End Date |
|---|---|---|
| 16131111000001105 | 14-10-2009 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Neostigmine bromide | Based on Ingredient Substance | 6 mg | 1 ml |
Name
Neostigmine bromide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
6
Strength and UOM (Dmr)
1
Parent Products
-
VTMNeostigmine
-
VMP(Current) Neostigmine 30mg/5ml oral solution
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |